Parallel findings indicate that HRG supports specific populations of tumor-associated macrophages, playing a key role in NAFLD progression to HCC, indicating HRG as a promising prognostic marker and therapeutic target (Foglia et al., 2024). Here, HRG is linked to metabolic dysfunction-associated steatotic liver disease.